德国 dystonia 的最佳肉毒毒素治疗:它会花费多少钱?
Dirk Dressler1,2, Eckart Altenmüller3, Lizhen Pan4,5
1Movement Disorders Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany. dressler.dirk@mh-hannover.de.
Journal of neural transmission (Vienna, Austria : 1996)
|December 24, 2024
概括
德国所有 dystonia 患者的最佳肉毒素 (BT) 治疗每年需要花费 155.5 亿欧元. 尽管个人药物成本很高,但BT治疗的整体医疗保健系统支出是边际的,这表明更广泛的获取潜力.
科学领域:
- 神经学 神经学
- 药物经济学 药物经济学
- 医学经济学 医学经济学
背景情况:
- 毒素 (BT) 治疗是大多数类型的 dystonia 的标准治疗方法.
- 了解最佳BT治疗的经济影响对于德国的医疗保健规划至关重要.
研究的目的:
- 估计德国所有 dystonia 患者的最佳肉毒素治疗的年度药物总成本.
- 将这些成本置于国家医疗保健预算中的背景,并将其与其他神经治疗方法进行比较.
主要方法:
- 采用了当前关于德国的 dystonia 流行病学和 BT 剂量要求的数据.
- 根据德国官方药店的销售价格计算出预计的年度药品成本.
- 生成缺少的流行病学和剂量数据,以确保全面分析.
主要成果:
- 德国所有 dystonia 患者的最佳 BT 治疗预计每年需要 155550 万欧元.
- 这相当于人均1.85欧元,占2021年药品总预算的0.3%.
- 预计成本明显高于实际的医疗保健支出,因为折扣和不同的访问.
结论:
- 虽然单个肉毒素 (BT) 治疗成本很高,但最佳 dystonia 治疗的总成本仅占德国医疗保健预算的边际部分.
- 预计和实际成本之间的差异凸显了德国 dystonia 患者的 BT 治疗的可用性和质量的潜在问题.
- 进一步分析与预计和实际成本进行比较,可以为改进获得和优化治疗 dystonia 的 BT 治疗提供提供策略提供信息.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
617
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
617
Skeletal Muscle Relaxants: Therapeutic Uses
438
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
438
Depolarizing Blockers: Pharmocokinetics
286
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
286
Myasthenia Gravis: Overview and Treatment
934
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
934


